Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements

ClinicalTrials.gov ID: NCT03005106

Public ClinicalTrials.gov record NCT03005106. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 6:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Open-label, Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of StrataGraft Skin Tissue in Promoting Autologous Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements and for Which Excision and Autografts Are Clinically Indicated

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

About 70 participants will be enrolled. They will have complex skin defects because of burns caused by heat. The burns will: * be on 3-49% of the participant's total body surface area (TBSA) * require surgery for skin replacement * include intact dermal elements The burns are called deep, partial-thickness thermal burns because the skin was damaged by heat but still has some dermis that was not damaged. The dermis is the layer of skin under the outer layer (epidermis). It is the thickest layer of the skin that provides strength and flexibility to the skin. All patients will receive both treatments, but on different areas of their burns. Their wounds will not be compared to other patients. One treatment area on their own body will be compared to the other one. This will help to find out if StrataGraft is safe and effective for deep partial thickness burns. It will also see if StrataGraft might help healing enough to use it instead of the patient's own healthy skin to repair the damage.

Study identification

NCT ID
NCT03005106
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
71 participants

Conditions and interventions

Conditions

Interventions

Biological · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 29, 2017
Primary completion
Jul 30, 2019
Completion
Mar 26, 2020
Last update posted
Jul 13, 2021

2017 – 2020

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
University of South Alabama Medical Center Mobile Alabama 36617
Arizona Burn Center at Maricopa Medical Center Phoenix Arizona 85008
Universtiy of California - Irvine Health Regional Burn Center Orange California 92868
UC Davis Sacramento California 95817
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
University of Florida Health Shands Burn Center Gainesville Florida 32610
Tampa General Hospital - Regional Burn Center Tampa Florida 33606
University of Iowa Iowa City Iowa 52242
Baton Rouge Medical Center Baton Rouge Louisiana 70809
University Medical Center New Orleans Louisiana 70112
University of Missouri Columbia Missouri 65212
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15219
Regional Medical Center Firefighters Burn Center Memphis Tennessee 38103
U.S. Army Institute of Surgical Research Adult Burn Center Fort Sam Houston Texas 78234-6315
University of Wisconsin Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03005106, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2021 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03005106 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →